Dysmenorrhea. Other obstetric conditions, not elsewhere classified
Conditions
Interventions
Intervention 1: cap Ibuprofen 200 mg + 25 drop placebo (Orally administrated every 6 hours (PO,QID) in the first 2 days of 2 subsequent cycles.). Intervention 2: 25 drops thymus vulgaris+ cap placebo
Treatment - Drugs
Placebo
cap Ibuprofen 200 mg + 25 drop placebo (Orally administrated every 6 hours (PO,QID) in the first 2 days of 2 subsequent cycles.)
25 drops thymus vulgaris+ cap placebo 200 mg ( Orally administrated every 6 hours (PO,QID) in the first 2 days of 2 subsequent cycles)
25 drops placebo + cap placebo 200 mg (Orally administrated every 6 hours (PO,QID) in the first 2 days of 2 subsequent cycles.)
Sponsors
Babol University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 24 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: single 18 to 24 years old midwifery and nursing students with no history of abdominal or pelvic surgery or any specific disease who were suffering from primary dysmenorrehea grade 1 or 2 Exclusion criteria: improper administration of the medication, administration of contraceptive pills or another medication whilst on research, history of allergies to origanum vulgare, severe stress, heavy exercise
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary dysmenorrhea. Timepoint: Prior to the intervention, 2 months after the initiation of intervention (2 first days of 2 subsequent cycles). Method of measurement: Visual analogue scale (VAS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRoshanak Saghebi
Babol University of Medical Sciences
Outcome results
None listed